EUVIMEDEUVIMED entdecken
Open Access

Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis

Tiezhu Shi, Xiao Li, Jiahao Zheng, Zonghao Duan, Yin Yin Ooi, Yan Gao, Qi Wang, Jianyu Yang, Lulu Wang, Linli Yao

Cellular Oncology · 2023

DOI: 10.1007/s13402-023-00791-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2023. Verfasst von Tiezhu Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Guangzhou University, 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center, Guangzhou, 510006, People's Republic of …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high mortality rate, in which about 90% of patients harbor somatic oncogenic point mutations in KRAS. SPRY family genes have been recognized as crucial negative regulators of Ras/Raf/ERK signaling. Here, we investigate the expression and role of SPRY proteins in PDAC. METHODS: Expression of SPRY genes in human and mice PDAC was analyzed using The Cancer Genome Atlas and Gene Expression Omnibus datasets, and by immunohistochemistry analysis. Gain-of-function, loss-of-function of Spry1 and orthotopic xenograft model were adopted to investigate the function of Spry1 in mice PDAC. Bioinformatics analysis, transwell and flowcytometry analysis were used to identify the effects of SPRY1 on immune cells. Co-immunoprecipitation and K-ras4B G12V overexpression were used to identify molecular mechanism. RESULTS: SPRY1 expression was remarkably increased in PDAC tissues and positively associated with poor prognosis of PDAC patients. SPRY1 knockdown suppressed tumor growth in mice. SPRY1 was found to promote CXCL12 expression and facilitate neutrophil and macrophage infiltration via CXCL12-CXCR4 axis. Pharmacological inhibition of CXCL12-CXCR4 largely abrogated the oncogenic functions of SPRY1 by suppressing neutrophil and macrophage infiltration. Mechanistically, SPRY1 interacted with ubiquitin carboxy-terminal hydrolase L1 to induce activation of nuclear factor κB signaling and ultimately increase CXCL12 expression. Moreover, SPRY1 transcription was dependent on KRAS mutation and was mediated by MAPK-ERK signaling. CONCLUSION: High expression of SPRY1 can function as an oncogene in PDAC by promoting cancer-associated inflammation. Targeting SPRY1 might be an important approach for designing new strategy of tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansMiceAnimalsNF-kappa BNeutrophilsProto-Oncogene Proteins p21(ras)Cell ProliferationMacrophagesGene Expression Regulation, NeoplasticMembrane ProteinsPhosphoproteinsChemokine CXCL12Receptors, CXCR4

Stichwörter der Autor:innen

ChemokinesKRAS mutationMicroenvironmentPancreatic cancerSPRY

Substanzen

NF-kappa BProto-Oncogene Proteins p21(ras)Membrane ProteinsPhosphoproteinsChemokine CXCL12SPRY1 protein, humanCXCL12 protein, humanCXCR4 protein, humanReceptors, CXCR4

Autor:innen und Institutionen

  • School of Life Sciences, Guangzhou University, 230 Wai Huan Xi Road, Guangzhou Higher Education Mega Center, Guangzhou, 510006, People's Republic of China.
  • Department of Obstetrics and Gynecology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China.
  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, People's Republic of China.
  • School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University. No. 1, Jalan Taylor's, Subang Jaya, Selangor, 47500, Malaysia.
  • Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, People's Republic of China.
  • Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Capital Medical University, Beijing, 100069, People's Republic of China.

Zitieren

APA

Shi, T., Li, X., Zheng, J., Duan, Z., Ooi, Y. Y., Gao, Y., Wang, Q., Yang, J., Wang, L., & Yao, L. (2023). Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis. Cellular Oncology. https://doi.org/10.1007/s13402-023-00791-z

Vancouver

Shi T, Li X, Zheng J, Duan Z, Ooi YY, Gao Y, et al. Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis. Cellular Oncology. 2023. doi:10.1007/s13402-023-00791-z

BibTeX
@article{Shi2023,
  author = {Shi, Tiezhu and Li, Xiao and Zheng, Jiahao and Duan, Zonghao and Ooi, Yin Yin and Gao, Yan and Wang, Qi and Yang, Jianyu and Wang, Lulu and Yao, Linli},
  title = {Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis},
  journal = {Cellular Oncology},
  year = {2023},
  doi = {10.1007/s13402-023-00791-z}
}
Kostenlos starten →